Spectrumedics
Shanghai, CN · 2 known investors
Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter. The medical device company serves interventional cardiologists and has received regulatory approval to market its product.
HardwareHealthtechMedical Devices
Investors · 2
Frequently asked questions
- What does Spectrumedics do?
- Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter. The medical device company serves interventional cardiologists and has received regulatory approval to market its product.
- Who are Spectrumedics's investors?
- Spectrumedics's investors include B Capital Group, B4 Capital.
- Where is Spectrumedics headquartered?
- Spectrumedics is headquartered in Shanghai, CN.